COMPOSTO, COMPOSIÇÃO FARMACÊUTICA E USO DE UM COMPOSTO

The present invention relates to novel cannabinoid receptor modulators, in particular cannabinoid 1 (CB1) or cannabinoid 2 (CB2) receptor modulators, and uses thereof for treating diseases, conditions and/or disorders modulated by a cannabinoid receptor (such as pain, neurodegenative disorders, eati...

Full description

Saved in:
Bibliographic Details
Main Authors SHRIDHAR NARAYANAN, KUMAR SUKEERTHI, SRINIVAS GULLAPALLI, BALASUBRAMANIAN GOPALAN, PALLAVI V. KARNIK, NEELIMA KHAIRATKAR JOSHI, MEYYAPPAN MUTHUPPALANTAPPAN
Format Patent
LanguagePortuguese
Published 25.02.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel cannabinoid receptor modulators, in particular cannabinoid 1 (CB1) or cannabinoid 2 (CB2) receptor modulators, and uses thereof for treating diseases, conditions and/or disorders modulated by a cannabinoid receptor (such as pain, neurodegenative disorders, eating disorders, weight loss or control, and obesity).
Bibliography:Application Number: BR2007PI16698